Due to COVID-19, the DIS office is closed to most in-person visitors. However, DIS staff are working remotely to serve you. We are committed to providing resources and guidance to the FDA community during this challenging and unprecedented time.
Please refer to this DIS webpage for important information regarding the impact of COVID-19 on FDA visiting scientists. These resources will be updated as new developments arise.
Candelario Zapata, Director, DIS
DIS sends alerts and newsletters via our listservs for scientists, administrators, and sponsors at the FDA. A compilation of our COVID-19 alerts for the FDA community can be accessed below:
Refer to these webpages for COVID-19 updates from various U.S. federal agencies and departments impacting FDA visiting scientists:
Feel free to contact us at DISFDA@mail.nih.gov with any questions.